Time To Launch Now Skip to main content

Posts

Showing posts with the label curing

How are some people's brains able to fight off Alzheimer's disease?

 How are some people's brains able to fight off Alzheimer's disease? Why do some people have the biological signs and damage of Alzheimer's disease , but their memory and intellectual abilities do not decline? Scientists have discovered the answer to this question. Why do some people have the biological signs and damage of Alzheimer's disease, but their memory and intellectual abilities do not decline? Scientists have discovered the answer to this question. According to researchers at the Netherlands Institute for Neuroscience , a rare and special type of immature cells in the brains of such people manage to survive and fight off the damage of the disease, so they do not show symptoms of Alzheimer's. The discovery, published in the journal Cell Stem Cell , raises hopes for the development of completely new treatments to slow the progression of dementia and preserve memory. Why does Alzheimer's disease affect people differently? This has always been a great myst...

GSK's drug is 60 percent more effective in curing cancer in women

 GSK's drug is 60 percent more effective in curing cancer in women World-renowned pharmaceutical company GSK has announced that the initial results of its new drug ' Mosertatag Rezedacan ', which is used to treat uterine and ovarian cancer , are encouraging. In the first phase of clinical trials, 'Mosertatag Rezedacan' has shown success in platinum-resistant ovarian cancer by 62 percent and in uterine cancer by 67 percent. GSK is preparing to start five large 'Phase-3' clinical trials in 2026 and the drug could change the way cancer is treated, said Hesham Abdullah. World-renowned pharmaceutical company GSK has announced that the initial results of its new drug used to treat uterine and ovarian cancer are very encouraging. The new antibody-drug conjugate (ADC) drug , called mosertatag rezedecan, has shown positive results in a phase 1 clinical trial. The BEHOLD-1 study , presented at the Society of Gynecologic Oncology (SGO) annual meeting in Puerto Rico, ...